Chitosan‐Gelatin‐EGCG Nanoparticle‐Meditated LncRNA TMEM44‐AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5‐FU Resistance in Gastric Cancer

Chemoresistance is one of the leading causes of therapeutic failure in gastric cancer (GC) treatment. Recent studies have shown lncRNAs play pivotal roles in regulating GC chemoresistance. Nanocarriers delivery of small interfering RNAs (siRNAs) to silence cancer‐related genes has become a novel app...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Mi, Dong, Jiaqi, Huang, Junqing, Ye, Wen, Zheng, Zhousan, Huang, Kangbo, Pan, Yihui, Cen, Junjie, Liang, Yanping, Shu, Guannan, Ye, Sheng, Lu, Xuanxuan, Zhang, Jiaxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353463/
https://www.ncbi.nlm.nih.gov/pubmed/35717675
http://dx.doi.org/10.1002/advs.202105077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353463/
https://www.ncbi.nlm.nih.gov/pubmed/35717675
http://dx.doi.org/10.1002/advs.202105077

Ejemplares similares